Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Final Trades: Vertex Pharma, Palantir, Wynn Resorts and Microsoft
01:38pm, Friday, 09'th May 2025
The Investment Committee give you their top names to watch for the second half.
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 09'th May 2025
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
4 No-Brainer Stocks to Buy Right Now
06:30am, Friday, 09'th May 2025
Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time. However, even in the current environment, there are excellent investment opportunities.
VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations
08:30am, Wednesday, 07'th May 2025
Sales from VRTX's new drugs, Casgevy, Alyftrek and Journavx, in Q1 fell short of investor expectations.
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip
04:49am, Wednesday, 07'th May 2025
Vertex Pharmaceuticals' (VRTX -9.39%) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date.
Vertex On Track To Significantly Improve Revenue And Earnings By 2030
10:12pm, Tuesday, 06'th May 2025
Vertex Pharmaceuticals reported decent Q1 earnings, but the company missed estimates for both revenue and earnings. Vertex's diversification efforts are most visible in the progress of its pain manage
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
04:28pm, Tuesday, 06'th May 2025
On Monday, Vertex Pharmaceuticals Incorporated VRTX reported lower-than-expected first-quarter 2025 earnings.
VRTX's Q1 Earnings Lag Estimates, 2025 Revenue View Tightened
01:00pm, Tuesday, 06'th May 2025
Vertex reports weaker-than-expected first-quarter 2025 results. The company tightens its total revenue guidance for 2025.
Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here's Why.
12:31pm, Tuesday, 06'th May 2025
The company discloses narrower-than-expected access to its new painkiller.
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
12:06pm, Tuesday, 06'th May 2025
U.S. equities were lower at midday as the market watched for any possible deals involving Trump administration tariffs and awaited tomorrow's statement from the Federal Reserve policymakers following
2 Pharma Stocks Staging Big Post-Earnings Moves
10:43am, Tuesday, 06'th May 2025
Biopharmaceutical giants Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Neurocrine Biosciences Inc (NASDAQ:NBIX) are fresh out of the earnings confessional, with very different results.
Why Vertex Pharmaceuticals Stock Is Sinking Today
10:36am, Tuesday, 06'th May 2025
Shares of Vertex Pharmaceuticals (VRTX -11.69%) were sinking 11.9% as of 10:18 a.m. ET on Tuesday.
Rising Costs Weigh on Vertex Q1 Earnings
09:11am, Tuesday, 06'th May 2025
Here's our initial take on Vertex Pharmaceuticals' (VRTX -0.27%) first-quarter financial report.
U.S. stock futures were lower this morning, with the Dow futures falling over 200 points on Tuesday.
Vertex: Improved Outlook Despite First Quarter Miss (Rating Upgrade)
08:04am, Tuesday, 06'th May 2025
Vertex Pharmaceuticals missed Q1 revenue and EPS estimates but this is not a cause for concern as the full-year outlook has improved. Alyftrek is off to a good start and early launch metrics of Journa
